Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.32 |
| ▸ | KRAS | P01116 | 1/20 | 0.30 |
| ▸ | FNTA | P49354 | 2/20 | 0.30 |
| ▸ | FNTB | P49356 | 2/20 | 0.30 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL483610 | 0.92 | TSHR (0.48) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL14678814 | 0.84 | TSHR (0.48) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL483453 | 0.81 | TDP1 (0.42) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL337894 | 0.75 | TSHR (0.44) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL16353777 | 0.73 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL844941 | 0.72 | TSHR (0.59) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL16353959 | 0.70 | ZDHHC20 (0.49) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL5161553 | 0.70 | TSHR (0.42) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL10626929 | 0.70 | TSHR (0.56) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 | |
| SCHEMBL907318 | 0.69 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1TDP1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841105-B2 | Organic-inorganic composite material and process for producing same | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2412677-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | National University Corporation Okayama University (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | RIOX2, MAOA, FTO | ALDH1A1 842/4885TSHR 3442/4885MAPK1 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.